Caterpillar Up Nearly 5%, On Pace for Largest Percent Increase Since December 2023 — Data Talk
Caterpillar Inc. (CAT) is currently at $372.70, up $17.58 or 4.95%
--Would be highest close since April 8, 2024, when it closed at $373.47
--On pace for largest percent increase since Dec. 14, 2023, when it rose 6.42%
--Currently up nine consecutive days; up 13.16% over this period
--Longest winning streak since March 4, 2024, when it rose for nine straight trading days
--Best nine day stretch since the nine days ending Dec. 19, 2023, when it rose 14.45%
--Up 4.66% month-to-date
--Up 26.05% year-to-date
--Down 1.74% from its all-time closing high of $379.30 on April 5, 2024
--Up 37.01% from 52 weeks ago (Sept. 21, 2023), when it closed at $272.03
--Down 1.74% from its 52-week closing high of $379.30 on April 5, 2024
--Up 64.88% from its 52-week closing low of $226.05 on Oct. 31, 2023
--Traded as high as $373.42; highest intraday level since April 15, 2024, when it hit $374.46
--Up 5.15% at today's intraday high; largest intraday percent increase since Feb. 5, 2024, when it rose as much as 6.28%
--Second best performer in the DJIA today
--
--Contributed 115.49 points to the DJIA so far today
All data as of 12:46:56 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 19, 2024 13:04 ET (17:04 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk